Jianmin Pharmaceutical Group Co Ltd (600976) — Working Capital to Net Assets Ratio

Latest as of March 2026: 35.7%

Jianmin Pharmaceutical Group Co Ltd (600976) has a Working Capital to Net Assets ratio of 35.7% as of March 2026. Working capital of CN¥987.05 Million (current assets of CN¥2.79 Billion minus current liabilities of CN¥1.81 Billion) is measured against net assets of CN¥2.77 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 600976 net asset quality score to measure how much of total assets are equity-financed.

WC/NA Ratio

35.7%
Working Capital / Net Assets

Working Capital

CN¥987.05 Million
CNY

Current Assets

CN¥2.79 Billion
CNY

Current Liabilities

CN¥1.81 Billion
CNY

Jianmin Pharmaceutical Group Co Ltd Working Capital to Net Assets (2001–2025)

This chart shows how Jianmin Pharmaceutical Group Co Ltd's Working Capital to Net Assets ratio has evolved across 25 annual periods from 2001 to 2025. As of March 2026, the ratio stands at 35.7%, reflecting working capital of CN¥987.05 Million against net assets of CN¥2.77 Billion CNY. Check 600976 tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Annual Working Capital to Net Assets for Jianmin Pharmaceutical Group Co Ltd (2001–2025)

The table below presents the year-by-year Working Capital to Net Assets ratio for Jianmin Pharmaceutical Group Co Ltd from 2001 to 2025, covering 25 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 600976 company net worth.

Year WC/NA Ratio Working Capital (CNY) Net Assets Current Assets Current Liabilities Change (pp)
2025 37.3% CN¥1.01 Billion CN¥2.72 Billion CN¥2.75 Billion CN¥1.74 Billion ▲ +2.3 pp
2024 34.9% CN¥856.33 Million CN¥2.45 Billion CN¥2.60 Billion CN¥1.75 Billion ▼ -5.3 pp
2023 40.3% CN¥908.95 Million CN¥2.26 Billion CN¥2.77 Billion CN¥1.86 Billion ▼ -1.0 pp
2022 41.3% CN¥771.06 Million CN¥1.87 Billion CN¥2.30 Billion CN¥1.53 Billion ▲ +0.9 pp
2021 40.4% CN¥633.41 Million CN¥1.57 Billion CN¥1.85 Billion CN¥1.22 Billion ▲ +6.7 pp
2020 33.7% CN¥445.44 Million CN¥1.32 Billion CN¥1.51 Billion CN¥1.07 Billion ▼ -5.4 pp
2019 39.1% CN¥472.36 Million CN¥1.21 Billion CN¥1.17 Billion CN¥698.34 Million ▼ -7.8 pp
2018 46.9% CN¥536.89 Million CN¥1.15 Billion CN¥1.10 Billion CN¥560.98 Million ▼ -5.2 pp
2017 52.1% CN¥576.78 Million CN¥1.11 Billion CN¥1.38 Billion CN¥804.27 Million ▼ -4.9 pp
2016 57.0% CN¥588.19 Million CN¥1.03 Billion CN¥1.35 Billion CN¥759.08 Million ▼ -5.3 pp
2015 62.3% CN¥621.31 Million CN¥997.36 Million CN¥1.21 Billion CN¥592.27 Million ▼ -3.2 pp
2014 65.5% CN¥656.43 Million CN¥1.00 Billion CN¥1.19 Billion CN¥529.30 Million ▲ +6.4 pp
2013 59.1% CN¥555.94 Million CN¥940.46 Million CN¥1.05 Billion CN¥490.48 Million ▲ +6.3 pp
2012 52.8% CN¥476.89 Million CN¥903.10 Million CN¥824.86 Million CN¥347.97 Million ▼ -12.0 pp
2011 64.8% CN¥568.24 Million CN¥876.97 Million CN¥858.58 Million CN¥290.34 Million ▲ +15.4 pp
2010 49.4% CN¥419.61 Million CN¥848.81 Million CN¥648.10 Million CN¥228.48 Million ▼ -5.1 pp
2009 54.6% CN¥447.70 Million CN¥820.32 Million CN¥922.80 Million CN¥475.09 Million ▲ +8.6 pp
2008 46.0% CN¥350.34 Million CN¥761.24 Million CN¥747.31 Million CN¥396.97 Million ▼ -8.1 pp
2007 54.1% CN¥401.82 Million CN¥742.63 Million CN¥543.76 Million CN¥141.95 Million ▲ +2.4 pp
2006 51.7% CN¥396.45 Million CN¥766.61 Million CN¥681.26 Million CN¥284.81 Million ▲ +2.8 pp
2005 48.9% CN¥371.61 Million CN¥759.65 Million CN¥671.00 Million CN¥299.40 Million ▼ -9.3 pp
2004 58.2% CN¥410.68 Million CN¥705.12 Million CN¥584.05 Million CN¥173.37 Million ▲ +32.8 pp
2003 25.4% CN¥73.76 Million CN¥290.32 Million CN¥266.70 Million CN¥192.93 Million ▼ -11.8 pp
2002 37.2% CN¥96.95 Million CN¥260.54 Million CN¥272.87 Million CN¥175.92 Million ▼ -5.7 pp
2001 42.9% CN¥100.26 Million CN¥233.57 Million CN¥257.56 Million CN¥157.30 Million
pp = percentage points